Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology

<br> A.A. Gvetadze<sup>1</sup>, M.G. Rabadanova<sup>1,2</sup><br> <sup>1</sup>City Clinical Hospital №15, Moscow, Russian Federation<br> <sup>2</sup>Pirogov Russian National Research Medical University, Moscow, Russian Federation&l...

Full description

Bibliographic Details
Main Authors: A.A. Gvetadze, M.G. Rabadanova
Format: Article
Language:Russian
Published: Prime-Media 2019-04-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/31f/31f2abaa8cc908ccc105cc9aac44848a.pdf
id doaj-af00f88742fd44889e5a473ab45bd969
record_format Article
spelling doaj-af00f88742fd44889e5a473ab45bd9692021-09-16T13:40:15ZrusPrime-Media РМЖ "Клиническая офтальмология"2311-77292619-15712019-04-0119130599Clinical trials on carotenoids and vitamin mineral supplements in ophthalmologyA.A. Gvetadze0M.G. Rabadanova1Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<br> A.A. Gvetadze<sup>1</sup>, M.G. Rabadanova<sup>1,2</sup><br> <sup>1</sup>City Clinical Hospital №15, Moscow, Russian Federation<br> <sup>2</sup>Pirogov Russian National Research Medical University, Moscow, Russian Federation<br> <br> This article reviews some of the large-scale multicentral clinical trials on lutein, zeaxanthin, and vitamins and minerals (AREDS 1, 2001; AREDS 2, 2006; LUNA, 2006; CARMA, 2006). The authors discuss etiology and pathogenesis of age-related macular degeneration (AMD) as well as the role of oxidative stress. Retinal protective effect of lutein and zeaxanthin is highlighted. Key markers of the efficacy of the preventive treatment with carotenoids were identified, i.e., increased macular pigment optical density, the presence of lutein and zeaxanthin in blood serum, and improved vision (visual acuity, contrast sensitivity etc.). Potential risks of the progression of early AMD to the advanced disease were calculated. Recent published data from these trials have systematized current information and enabled to perform meta-analysis of trials on vitamin mineral supplements.<br> <br> <b>Key words:</b> carotenoids, nutrients, oxidative stress, vitamin mineral supplements, lutein, zeaxanthin, antioxidant, retinal protection, macular pigment optical density, age-related macular degeneration, clinical trials, meta-analysis.<br> <b>For citation:</b> Gvetadze A.A., Rabadanova M.G. Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology. Russian Journal of Clinical Ophthalmology. 2019;19(1):38–41.<br> <br> <b>About the authors:</b><br> <sup>1</sup>Anna A. Gvetadze — MD, PhD, ophthalmologist;<br> <sup>1,2</sup>Madina G. Rabadanova — MD, PhD, Associate Professor of Ophthalmology Department, ophthalmologist.<br> <sup>1&nbsp;</sup>City Clinical Hospital №15. 23, Veshnyakovskaya str., Moscow, 111539, Russian Federation.<br> <sup>2</sup>Pirogov Russian National Research Medical University. 1, Ostrovityanova str., Moscow, 117997, Russian Federation.<br> <b>Contact information:</b>&nbsp;Anna A. Gvetadze, e-mail:&nbsp;<a href="mailto:gvetadzanya@mail.ru">gvetadzanya@mail.ru</a>.<b>&nbsp;Financial Disclosure</b>: no authors have a financial or property interest in any material or method mentioned. There is no&nbsp;<b>conflict of interests. Received</b>&nbsp;09.11.2018.<br>http://clinopht.com/upload/iblock/31f/31f2abaa8cc908ccc105cc9aac44848a.pdf
collection DOAJ
language Russian
format Article
sources DOAJ
author A.A. Gvetadze
M.G. Rabadanova
spellingShingle A.A. Gvetadze
M.G. Rabadanova
Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology
РМЖ "Клиническая офтальмология"
author_facet A.A. Gvetadze
M.G. Rabadanova
author_sort A.A. Gvetadze
title Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology
title_short Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology
title_full Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology
title_fullStr Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology
title_full_unstemmed Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology
title_sort clinical trials on carotenoids and vitamin mineral supplements in ophthalmology
publisher Prime-Media
series РМЖ "Клиническая офтальмология"
issn 2311-7729
2619-1571
publishDate 2019-04-01
description <br> A.A. Gvetadze<sup>1</sup>, M.G. Rabadanova<sup>1,2</sup><br> <sup>1</sup>City Clinical Hospital №15, Moscow, Russian Federation<br> <sup>2</sup>Pirogov Russian National Research Medical University, Moscow, Russian Federation<br> <br> This article reviews some of the large-scale multicentral clinical trials on lutein, zeaxanthin, and vitamins and minerals (AREDS 1, 2001; AREDS 2, 2006; LUNA, 2006; CARMA, 2006). The authors discuss etiology and pathogenesis of age-related macular degeneration (AMD) as well as the role of oxidative stress. Retinal protective effect of lutein and zeaxanthin is highlighted. Key markers of the efficacy of the preventive treatment with carotenoids were identified, i.e., increased macular pigment optical density, the presence of lutein and zeaxanthin in blood serum, and improved vision (visual acuity, contrast sensitivity etc.). Potential risks of the progression of early AMD to the advanced disease were calculated. Recent published data from these trials have systematized current information and enabled to perform meta-analysis of trials on vitamin mineral supplements.<br> <br> <b>Key words:</b> carotenoids, nutrients, oxidative stress, vitamin mineral supplements, lutein, zeaxanthin, antioxidant, retinal protection, macular pigment optical density, age-related macular degeneration, clinical trials, meta-analysis.<br> <b>For citation:</b> Gvetadze A.A., Rabadanova M.G. Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology. Russian Journal of Clinical Ophthalmology. 2019;19(1):38–41.<br> <br> <b>About the authors:</b><br> <sup>1</sup>Anna A. Gvetadze — MD, PhD, ophthalmologist;<br> <sup>1,2</sup>Madina G. Rabadanova — MD, PhD, Associate Professor of Ophthalmology Department, ophthalmologist.<br> <sup>1&nbsp;</sup>City Clinical Hospital №15. 23, Veshnyakovskaya str., Moscow, 111539, Russian Federation.<br> <sup>2</sup>Pirogov Russian National Research Medical University. 1, Ostrovityanova str., Moscow, 117997, Russian Federation.<br> <b>Contact information:</b>&nbsp;Anna A. Gvetadze, e-mail:&nbsp;<a href="mailto:gvetadzanya@mail.ru">gvetadzanya@mail.ru</a>.<b>&nbsp;Financial Disclosure</b>: no authors have a financial or property interest in any material or method mentioned. There is no&nbsp;<b>conflict of interests. Received</b>&nbsp;09.11.2018.<br>
url http://clinopht.com/upload/iblock/31f/31f2abaa8cc908ccc105cc9aac44848a.pdf
work_keys_str_mv AT aagvetadze clinicaltrialsoncarotenoidsandvitaminmineralsupplementsinophthalmology
AT mgrabadanova clinicaltrialsoncarotenoidsandvitaminmineralsupplementsinophthalmology
_version_ 1717378251985256448